Skip to content
10-Q

Quarterly Report

FIRST CHINA PHARMACEUTICAL GROUP, INC.

0001062993-12-004979

← back to feed
Filed
Nov 19, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Nov 12, 2012 59.66M sh
Shares Diluted Q3 2012 · Sep 30, 2012 59.66M sh
Shares Diluted Q3 2012 · Sep 30, 2012 59.66M sh
Shares Diluted restated Q3 2012 · Sep 30, 2011 59.66M sh
Shares Diluted restated Q3 2012 · Sep 30, 2011 58.2M sh
Capex Q3 2012 · Sep 30, 2012 $33.59K
Capex Q3 2012 · Sep 30, 2011 $35.86K
Operating Cash Flow Q3 2012 · Sep 30, 2012 −$218.42K
Operating Cash Flow restated Q3 2012 · Sep 30, 2011 −$3.14M
Short Term Debt Q3 2012 · Sep 30, 2012 $3.26M
Short Term Debt Q3 2012 · Dec 31, 2011 $0
Cash And Equivalents Q3 2012 · Sep 30, 2012 $6.4M
Cash And Equivalents Q3 2012 · Dec 31, 2011 $3.64M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $711.9K
Cash And Equivalents Q3 2012 · Dec 31, 2010 $1.13M
Stockholders Equity Q3 2012 · Sep 30, 2012 −$4.87M
Stockholders Equity Q3 2012 · Dec 31, 2011 −$6.01M
Current Liabilities Q3 2012 · Sep 30, 2012 $23.06M
Current Liabilities Q3 2012 · Dec 31, 2011 $16.15M
Total Liabilities Q3 2012 · Sep 30, 2012 $25.06M
Total Liabilities Q3 2012 · Dec 31, 2011 $17.84M
Current Assets Q3 2012 · Sep 30, 2012 $19.27M
Current Assets Q3 2012 · Dec 31, 2011 $11.76M
Total Assets Q3 2012 · Sep 30, 2012 $20.19M
Total Assets Q3 2012 · Dec 31, 2011 $11.82M
Eps Diluted Q3 2012 · Sep 30, 2012 $0.02
Eps Diluted Q3 2012 · Sep 30, 2012 $0.02
Eps Diluted restated Q3 2012 · Sep 30, 2011 $0.01
Eps Diluted restated Q3 2012 · Sep 30, 2011 $0.04
Eps Basic Q3 2012 · Sep 30, 2012 $0.02
Eps Basic Q3 2012 · Sep 30, 2012 $0.02
Eps Basic restated Q3 2012 · Sep 30, 2011 $0.01
Eps Basic restated Q3 2012 · Sep 30, 2011 $0.04
Sga Expense Q3 2012 · Sep 30, 2012 $584.89K
Sga Expense Q3 2012 · Sep 30, 2012 $1.48M
Sga Expense Q3 2012 · Sep 30, 2011 $338.4K
Sga Expense restated Q3 2012 · Sep 30, 2011 $1.36M
Net Income Q3 2012 · Sep 30, 2012 $990.98K
Net Income Q3 2012 · Sep 30, 2012 $1.11M
Net Income restated Q3 2012 · Sep 30, 2011 $836.19K
Net Income restated Q3 2012 · Sep 30, 2011 $2.17M
Operating Income Q3 2012 · Sep 30, 2012 $1.05M
Operating Income Q3 2012 · Sep 30, 2012 $2.41M
Operating Income Q3 2012 · Sep 30, 2011 $656.74K
Operating Income restated Q3 2012 · Sep 30, 2011 $1.63M
Gross Profit Q3 2012 · Sep 30, 2012 $1.75M
Gross Profit Q3 2012 · Sep 30, 2012 $4.21M
Gross Profit Q3 2012 · Sep 30, 2011 $1.02M
Gross Profit restated Q3 2012 · Sep 30, 2011 $3.66M
Cost Of Revenue Q3 2012 · Sep 30, 2012 $15.64M
Cost Of Revenue Q3 2012 · Sep 30, 2012 $39.33M
Cost Of Revenue Q3 2012 · Sep 30, 2011 $13.21M
Cost Of Revenue restated Q3 2012 · Sep 30, 2011 $29.58M
Revenue Q3 2012 · Sep 30, 2012 $17.38M
Revenue Q3 2012 · Sep 30, 2012 $43.54M
Revenue Q3 2012 · Sep 30, 2011 $14.22M
Revenue restated Q3 2012 · Sep 30, 2011 $33.24M